We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Inhaler Sales Driving Global Respiratory Device Market

By HospiMedica International staff writers
Posted on 30 May 2012
A new study shows the respiratory market reached USD 44.2 billion 2011 as a result of a worldwide increase in respiratory disease and an aging population.

In a recent research report titled World Market for Respiratory Devices, Kalorama Information (Kalorama; Rockville, MD, USA), a medical research publisher, examined the size and growth of the respiratory device market to determine trends in the industry.

Kalorama’s report showed that growth in the market is the result of an increased incidence of Chronic obstructive pulmonary disease (COPD) and a need for home-based care products, according to Bruce Carlson, publisher, Kalorama.

“The bulk of the market growth is expected to arise from an increasing incidence of COPD worldwide and from innovative products entering the market,” said Mr. Carlson. “The market will also grow thanks to the shifting trend towards the use of home care products for the graying population across the globe.”

Respiratory market products include inhalers, nebulizers, sleep apnea equipment, oxygen therapy equipment, medical humidifiers, and respiratory measurement devices. Kalorama’s report also discovered the largest component of the market is respiratory inhalers and therapeutic pharmaceuticals, which account for roughly 77% of the total sales for the industry.

Devices that contain pharmaceuticals administered through an inhaler represent the largest volume of market sales. However, Kalorama notes that the dollar volume of inhalers should not mask the growth opportunities in other device categories.

“The lion’s share of the market is inhalers, but there are other devices that are going to drive revenue growth as well, and we detail these in the report,” added Carlson.

The report indicated that some industry areas will experience growth of 7%-9% over the next five years.

Kalorama Information is a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries.


Related Links:
Kalorama Information


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Diagnostic Ultrasound System
MS1700C
New
Transducer Covers
Surgi Intraoperative Covers

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex